Mohamed Kane is a founder and machine learning leader with 11 years of experience building applied AI systems across biotech and enterprise SaaS. As Co-Founder & CEO of Medium Biosciences in San Francisco he leads development of AI models and novel assays to design functional therapeutic proteins, backed by Y Combinator and top biotech investors. He previously led ML at a startup acquired by focusing on multimodal transformer models for customer support, and has consulted on deep learning for antibody optimization with lab-validated results. Earlier roles include CTO of a sustainability-tech startup where he built and scaled an engineering org, and internships at Uber ATG and Facebook that grounded his work in perception and production systems. Trained at MIT and shaped by startup ecosystems like YC, he combines hands-on model deployment experience with a rare cross-domain fluency in ML, software engineering and protein science. Colleagues note he moves fluidly between research-grade models and production APIs, prioritizing measurable lab or business impact.
11 years of coding experience
4 years of employment as a software developer
Bachelor of Science - BS Computer Science, Bachelor of Science - BS Computer Science at Massachusetts Institute of Technology
Summer 2021 (S21) Batch, Summer 2021 (S21) Batch at Y Combinator
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.